C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/08/2001	WO2001083712A1 Method of forming vertebrate pancreas in vitro
11/08/2001	WO2001083711A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
11/08/2001	WO2001083710A2 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	WO2001083701A2 Light-driven energy generation using proteorhodopsin
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083697A2 System for functional gene discovery in plants
11/08/2001	WO2001083692A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	WO2001083691A2 System for identifying and analyzing expression of are-containing genes
11/08/2001	WO2001083678A2 A novel polypeptide, homo uridylic acid kinase 13 and polynucleotide encoding said polypeptide
11/08/2001	WO2001083621A2 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
11/08/2001	WO2001083563A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
11/08/2001	WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083559A2 Production and use of protein variants having modified immunogenecity
11/08/2001	WO2001083558A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
11/08/2001	WO2001083557A1 A novel polypeptide, a cellular factor receptor 10 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083553A2 G protein-coupled receptors
11/08/2001	WO2001083550A2 Gpr22 modulators as appetite-control agents
11/08/2001	WO2001083549A2 Novel polypeptides constituting pheromone receptors in rats, cloning and use thereof
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083545A1 Novel proetin and use thereof
11/08/2001	WO2001083544A1 A novel polypeptide, a human pax protein 18 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083542A1 A novel polypeptide, human p18 protein 21 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083541A1 A novel polypeptide-human kruppel associated dna binding protein 42 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083540A1 A novel polypeptide-kiaa0883-44 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083539A1 A novel polypeptide, a mitotic kinase ask1-26 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083538A1 A novel polypeptide, a human k-ras gene protein 36 and the polynucleotide
11/08/2001	WO2001083537A1 A novel polypeptide, a human phospholipase 9 and the polynucleotide encoding the polypeptide
11/08/2001	WO2001083536A1 A novel polypeptide-cytokine receptor 15 and the polynucleotide encoding said polypeptide
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083523A2 Stmst protein and nucleic acid molecules and uses therefor
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001083513A2 Antisense modulation of inhibitor of dna binding-1 expression
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001083508A1 Antisense modulation of zinc finger protein-217 expression
11/08/2001	WO2001083503A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
11/08/2001	WO2001083502A1 Tag library compounds, compositions, kits and methods of use
11/08/2001	WO2001083072A1 Polynucleotide separations on polymeric separation media
11/08/2001	WO2001082973A2 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
11/08/2001	WO2001082968A1 Cell proliferation inhibitors
11/08/2001	WO2001082964A1 Improved immunogenicity using a combination of dna and vaccinia virus vector vaccines
11/08/2001	WO2001082963A2 Method of identifying and producing antigen peptides and use thereof as vaccines
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082900A1 Non-invasive gene targeting to the brain
11/08/2001	WO2001082780A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
11/08/2001	WO2001082699A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	WO2001082688A1 Rab GDI alpha KNOCKOUT ANIMALS
11/08/2001	WO2001082685A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides
11/08/2001	WO2001053478A9 Methods for regulating transcription in plants by introduction of engireed zinc finger polypeptides
11/08/2001	WO2001049886A8 Method of analyzing a nucleic acid
11/08/2001	WO2001046474A8 Detection of nucleic acids
11/08/2001	WO2001044276A3 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols carotenoids and aromatic amino acids
11/08/2001	WO2001042448A3 Artificial promoters for protein expression in plants
11/08/2001	WO2001042435A3 Novel human kinase proteins and polynucleotides encoding the same
11/08/2001	WO2001042279A3 Complementary peptide ligands generated from plant genomes
11/08/2001	WO2001040490A3 Eukaryotic initiation factor 4e inhibitors and their use as herbicides
11/08/2001	WO2001040460A8 Screening method for compounds capable of modularing egr-1-regulated expression
11/08/2001	WO2001038872A3 Assay of isomerised and/or optically inverted proteins
11/08/2001	WO2001038564A3 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
11/08/2001	WO2001038348A3 G-protein coupled receptor htogh35
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001036489A3 Erythropoietin forms with improved properties
11/08/2001	WO2001034780A3 Cytochrome p450 oxygenases and their uses
11/08/2001	WO2001032904A3 Method for enhancing secretion of beta-lactam compounds
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13
11/08/2001	WO2001031040A3 Host-vector systems in order to over-produce thermolabile enzymes originating from psychrophilic organisms
11/08/2001	WO2001029238A3 Elongase promoters for the tissue-specific expression of transgenes in plants
11/08/2001	WO2001029068A3 A eag gene encoding for a potassium channel
11/08/2001	WO2001025455A3 Promoter for regulating expression of foreign genes
11/08/2001	WO2001025454A3 Method for regulating transcription of foreign genes in the presence of nitrogen
11/08/2001	WO2001025453A3 Plant fatty acid desaturases and alleles therefor
11/08/2001	WO2001025449A3 Novel immobilizable amylosucrase, the use thereof and method for producing poly(1,4-alpha-glucan)
11/08/2001	WO2001023553A3 Metastasis-associated antigen c4.4a
11/08/2001	WO2001023414A3 Immunologically significant herpes simplex virus antigens
11/08/2001	WO2001018240A3 Diagnostic and therapeutic methods in autoimmune disease
11/08/2001	WO2001018194A3 Maize casein kinase 1 orthologue and uses thereof
11/08/2001	WO2001018035A3 Muc-1 derived peptides
11/08/2001	WO2001009352A3 Use of aspergillus sojae as host for recombinant protein production
11/08/2001	WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/08/2001	WO2001005963A3 ANTISENSE OLIGONUCLEOTIDES FOR METABOTROPIC GLUTAMATE RECEPTOR TYPE 1 (mGluR1)
11/08/2001	WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics
11/08/2001	WO2000079008B1 High throughput assay system
11/08/2001	WO2000066607A9 Detection using degradation of a tagged sequence
11/08/2001	WO2000053775A9 Prevention and treatment of viral infections
11/08/2001	WO2000053745A9 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
11/08/2001	WO2000042221A9 Method for the affinity isolation of newly synthesized rna
11/08/2001	WO2000006713A8 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
11/08/2001	WO1999051621A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/08/2001	US20010039670 Oxidative stress resistance gene
11/08/2001	US20010039669 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
11/08/2001	US20010039668 In ovo activation of an egg in the shell
11/08/2001	US20010039667 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease

1 ... 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 ... 4023